|
Appendix
3D Systems Corporation Unaudited Reconciliations of GAAP to Non-GAAP Measures Three and Six Months Ended June 30, 2023 and 2022 . | ||||||||||||||||||
|
Constant Currency Revenue
(4)
| ||||||||||||||||||
| Three Months Ended June 30, | Constant Currency (1) | |||||||||||||||||
| (in thousands) | 2023 | 2022 | $ Change | % Change | FX Effect (2) | % Change (3) | ||||||||||||
| Healthcare Solutions | $ | 60,874 | 71,746 | $ | (10,872 | ) | (15.2 | )% | $ | 181 | (15.4 | )% | ||||||
| Industrial Solutions | 67,320 | 68,299 | (979 | ) | (1.4 | )% | 193 | (1.7 | )% | |||||||||
| Total revenue | $ | 128,194 | $ | 140,045 | $ | (11,851 | ) | (8.5 | )% | $ | 374 | (8.7 | )% | |||||
|
3D Systems Reports Second Quarter 2023 Financial Results
(a) The amounts for cash and cash equivalents and restricted cash shown above include restricted cash of $1,277 and $114 as of June 30, 2023 and December 31, 2022, respectively, which are included in prepaid expenses and other current assets. In addition, included in cash and cash equivalents and restricted cash above as of June 30, 2023 and December 31, 2022 is $291 and $3,727, respectively, of restricted cash, which, is included in other non-current assets. The amounts for cash and cash equivalents and restricted cash shown above include restricted cash of $1,105 and $313 as of June 30, 2022 and December 31, 2021, respectively.
|
|
||||||
|
|
|||||||
|
|||||||
